Publication
Habitual and Recent Sleep Durations: Graded and Interactive Risk for Impaired Glycemic Control in a Biracial Population
Downloadable Content
- Persistent URL
- Last modified
- 05/21/2025
- Type of Material
- Authors
-
-
Donald Bliwise, Emory UniversitySophia A. Greer, Emory UniversityMichael K. Scullin, Emory UniversityLawrence S Phillips, Emory University
- Language
- English
- Date
- 2017-05-01
- Publisher
- Elsevier: 12 months
- Publication Version
- Copyright Statement
- © 2017 Elsevier Inc. All rights reserved.
- License
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 0002-9343
- Volume
- 130
- Issue
- 5
- Start Page
- 564
- End Page
- 571
- Grant/Funding Information
- This work was supported in part by NIH awards DK066204 (LSP), DK099716 (LSP), NS050595 (DLB), AG041543 (MKS), and UL1 RR025008 (LSP), VA award HSR&D IIR 07-138 (LSP), Cystic Fibrosis Foundation award PHILLI12A0 (LSP), Emory Neuroscience Initiative Award (DLB); and the United States Department of Veterans Affairs (LSP).
- LSP is also supported in part by the Department of Veterans Affairs (VA).
- Abstract
- Background We examined how habitual sleep duration interacts with recent sleep (2 nights) to predict morning oral glucose tolerance test results. We hypothesized that short habitual and recent sleep durations would be additive for poor glucose control. Methods A biracial population of adults (n = 1559) without known diabetes and recruited from the workforce of 2 urban universities was assessed for glycated hemoglobin and underwent oral glucose tolerance testing. We used plasma 2-hour postloading (75 g) measurements. Participants answered sleep questions using 30-minute forced-choice formats. We employed multivariable logistic regression to derive odds ratios. Results Shorter habitual sleep duration was associated with greater odds ratios of glycated hemoglobin ≥6.0% increasing by 30-minute intervals beginning at < 7.0 hours and were more pronounced as durations shortened. Among participants with glycated hemoglobin < 6.0% and < 7.0 hours of habitual sleep (n = 636), abnormal glucose tolerance (2-hour oral glucose tolerance test ≥140 mg/dL) was significantly associated with a total sleep duration of ≤11 hours the 2 nights preceding oral glucose tolerance testing, but was not associated with longer sleep durations. Results were independent of age, sex, race, body mass index, smoking, history of cardiovascular disease, or use of antihypertensive or cholesterol-lowering medication. Additional analyses implied that longer-than-usual recent sleep durations were protective for abnormal oral glucose tolerance testing. Discussion Short habitual and recent sleep durations interact in predicting abnormal glucose on oral glucose tolerance testing. Self-reported data are sufficiently sensitive to reflect 30-minute differences in sleep between individuals. Future studies examining other aspects of sleep, such as perceived sleep quality and objectively measured sleep duration and architecture, would be necessary to confirm these findings. Conclusions Short sleep duration for 2 nights prior to morning oral glucose tolerance testing may elevate glucose levels, this effect being detected among individuals habitually obtaining < 7 hours sleep and obtaining ≤11 hours of sleep for 2 nights preceding testing.
- Author Notes
- Keywords
- Research Categories
- Biology, Biostatistics
- Biology, Neuroscience
- Health Sciences, Nutrition
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - s9jdq.pdf | Primary Content | 2025-03-15 | Public | Download |